Delivery Order SPE2DB25D3504-SPE2DB25FVWCN
- Not listed
- The Defense Logistics Agency awarded a $21,282.14 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 40 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside, firm fixed-price contract represents a delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $31,892.74 delivery order to AmerisourceBergen Drug Corp for TAGRISSO (80 mg tablets, 30-count package) under a firm fixed-price contract type. The award was issued on September 17, 2025, with an ultimate completion date of October 8, 2025, and represents a competitively awarded non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, leveraging its established...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on August 19, 2025, with completion targeted for September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 20, 2025, for the supply of TAGRISSO 80 mg tablets (30-count units) with a contract value of $10,662.57. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 11, 2025, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a $21,282.14 delivery order to AmerisourceBergen Drug Corp for the supply of TAGRISSO 40 mg tablets (30-count units) under a firm fixed-price contract. The award was made on September 19, 2025, with an ultimate completion date of October 10, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award, reflecting the contractor's capability to...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on September 3, 2025, with completion scheduled for September 24, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,325.14 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count units) under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by July 14, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $127,093.14. The delivery order, awarded on August 27, 2025, is scheduled for ultimate completion by September 18, 2025. This is a competitive award with no set-aside designation, and performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a $10,662.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count) on August 11, 2025, with completion scheduled for September 2, 2025. This non-set-aside award represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a $10,662.57 firm fixed price delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count packages) on August 11, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside contract represents a competitive award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVWCNDelivery Order
The Defense Logistics Agency awarded a $21,325.14 delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) under a firm fixed price contract type. This competitive award, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured among qualified vendors. This delivery order falls under AmerisourceBergen's comprehensive $999.99 billion DLA Troop Support Medical IDC (SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, provides critical medical supplies including brand-name and generic medications to federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates consistent capability to fulfill diverse pharmaceutical procurement requirements through open competition, with previous delivery orders ranging substantially in value and covering multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.3k | 8/26/25 |